Latest neurological disorders Stories
Gustavo C. Román M.D., Professor of Neurology, Weill Cornell Medical College and Director of The Nantz National Alzheimer Center a scholarly partnership between The Methodist Hospital Research Institute, Weill Cornell Medical College, and the Weill Cornell Graduate School of Medical Sciences of Cornell University., to join board of LightBridge Healthcare Research, Inc. San Antonio, Texas (PRWEB) July 30, 2012 The Alzheimer’s Caregiver™ today announced that Gustavo C. Román...
Alternating hemiplegia of childhood (AHC) is a very rare disorder that causes paralysis that freezes one side of the body and then the other in devastating bouts that arise at unpredictable intervals. Seizures, learning disabilities and difficulty walking are common among patients with this diagnosis. Researchers at Duke University Medical Center have now discovered that mutations in one gene cause the disease in the majority of patients with a diagnosis of AHC, and because of the root...
PHILADELPHIA, July 26, 2012 /PRNewswire/ -- The Intellectual Property & Science business of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today announced a partnership with CHDI Foundation, Inc. to develop systems biology tools for Huntington's disease (HD) research. HD is a devastating neurodegenerative disorder that affects muscle coordination and leads to gradual cognitive decline and dementia; there are currently no...
ROCKVILLE, Md., July 26, 2012 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that it received a notice of issuance for patent number 12/710,097 titled: "Transplantation of Human Neural Cells for Treatment of Neurodegenerative Conditions." This patent covers both the culturing of central nervous system cells as well as their transplantation into spinal cord tissue to treat neurodegenerative conditions, including amytrophic lateral sclerosis (ALS or Lou Gehrig's disease)....
In a study published June 25 in the Journal of Neuroscience, a collaborative team of researchers led by Linda J. Van Eldik, director of the University of Kentucky Sanders-Brown Center on Aging, and D. Martin Watterson of the Northwestern University Feinberg School of Medicine, present results showing that a new central nervous system drug compound can reduce Alzheimer's pathology in a mouse model of the disease. The drug, called MW-151, is a selective suppressor of brain inflammation and...
1-size-fits-all drug targets harmful brain inflammation in many diseases A new class of drug developed at Northwestern University Feinberg School of Medicine shows early promise of being a one-size-fits-all therapy for Alzheimer's disease, Parkinson's disease, multiple sclerosis and traumatic brain injury by reducing inflammation in the brain. Northwestern has recently been issued patents to cover this new drug class and has licensed the commercial development to a biotech company that...
NEWPORT, R.I., July 25, 2012 /PRNewswire/ -- Migraine can be a disabling neurological disorder, often aggravated by accompanying nausea. Stimulation of the acupoint PC6 Neiguan, an approach to controlling nausea adopted by traditional Chinese medicine, has never been documented by published clinical studies in medical literature for the control of migraine-related nausea, until now. Published in the May 2012 Neurological Sciences (journal of the Italian Neurological Society)(1),...
RALEIGH, N.C., July 24, 2012 /PRNewswire/ -- PRA, a leading Clinical Research Organization, announces that it is participating in a groundbreaking Alzheimer's disease study that could lead to treatments delaying or even preventing the emergence of symptoms in people destined to develop the disease because of their genetic background. The clinical trial is a collaborative effort involving the Banner Alzheimer's Institute (BAI); Genentech, a member of the Roche Group (SIX: RO, ROG;...
MENLO PARK, Calif, July 23, 2012 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) today announced that a report of Phase 3 data published online this month, ahead of the print edition, in the Clinical Journal of Pain showed that once-daily Gralise(®) (gabapentin) tablets (1,800 mg) formulation significantly reduces intensity of pain in patients with postherpetic neuralgia (PHN). The results showed that patients treated with Gralise experienced a significant reduction (- 2.12) in...
(Ivanhoe Newswire) – Memories - we spend our whole lives making them, but imagine your brain being wiped of all your precious moments. For 5.4 million Americans living with Alzheimer's, memory loss is a part of life. Researchers now link the condition to your walking pattern. Problems walking, including slow gait and a short stride, are associated with an increased risk of cognitive decline. Researchers measured the stride length, cadence and velocity of more than 1,341 participants...
Latest neurological disorders Reference Libraries
Cephalalgia is a peer-reviewed medical journal published by SAGE Publications on behalf of the International Headache Society. The journal is subtitled 'An International Journal of Headache'. The journal was established in 1981 and is published tri-weekly (or 16 times per year). It was previously published by Blackwell Publishing. The editor-in-chief is David W. Dodick of Mayo Clinic College of Medicine. Cephalalgia provides an international forum for research, review and discussions on...
St. Louis Encephalitis is a disease caused by the Culex mosquito borne St. Louis Encephalitis virus. It is related to Japanese encephalitis virus and is a member of the Flaviviridae subgroup. It mainly affects the United States and occasionally hits Canada and Mexico. The name goes back to 1933 within five weeks in autumn an encephalitis epidemic of explosive proportions broke out in the vicinity of St. Louis, Missouri. Over 1000 cases were reported and the National Institute of Health...
Lymphocytic choriomeningitis (LCM) is a viral disease, spread by rodents, that presents as aseptic meningitis, encephalitis, or meningoencephalitis. Lymphocytic Choriomeningitis Virus (LCMV) is the causative agent and is a member of the Arenaviridae family. The name is from the tendency of an individual to have high levels of lymphocytes during infection. It is spread by the common house mouse. Mice become chronically infected by keeping the virus in their blood. Female mice will...
